The major new findings of this study are that autologous MSCs secrete higher levels of SDF-1α in vitro than allogeneic MSCs, and that these levels inversely correlate with EPC bioactivity in DCM patients. Here, CXCL12 is linked to familial dilated cardiomyopathy.